Loading ...

Stock Quote cth

cth Stock Price Today

cth Price History

cth Stock Price History

cth History

Last Price cth

Close Price cth

Day Change cth

After Hours Quote cth

Open Price cth

Day Range cth

Year Range cth

Projected Yield cth

Market Cap cth

Stock Volume cth

Average Volume cth

Forward Price cth

PE for cth

PB for cth

PS for cth

PCF for cth

price earnings ratio cth

price to book ratio cth

price to sales ratio cth

price to cash flow ratio cth

Stock Quote Cynapsus Therapeutics Inc

Cynapsus Therapeutics Inc Stock Price today

Cynapsus Therapeutics Inc Price history

Cynapsus Therapeutics Inc Stock Price history

Cynapsus Therapeutics Inc history

Last Price Cynapsus Therapeutics Inc

Close Price Cynapsus Therapeutics Inc

Day Change Cynapsus Therapeutics Inc

After Hours Quote for Cynapsus Therapeutics Inc

Open Price Cynapsus Therapeutics Inc

Day Range Cynapsus Therapeutics Inc

Year Range Cynapsus Therapeutics Inc

Projected Yield Cynapsus Therapeutics Inc

Market Cap Cynapsus Therapeutics Inc

Stock Volume Cynapsus Therapeutics Inc

Average Volume Cynapsus Therapeutics Inc

Forward Price Cynapsus Therapeutics Inc

pe Cynapsus Therapeutics Inc

pb Cynapsus Therapeutics Inc

ps Cynapsus Therapeutics Inc

pcf Cynapsus Therapeutics Inc

price earnings ratio Cynapsus Therapeutics Inc

price to book ratio Cynapsus Therapeutics Inc

price to sales ratio Cynapsus Therapeutics Inc

price to cash flow ratio Cynapsus Therapeutics Inc

What Does This Company Do?
Cynapsus Therapeutics, Inc., is a specialty pharmaceutical company. The Company is engaged in developing a convenient and easy to use sublingual thin film strip for the acute rescue of, off motor symptoms of Parkinson’s disease.
Sector
Healthcare
Industry
Biotechnology
Stock Type
Employees
8
Stock Style

Key Stats  CTH More...

Key Stats CTH

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

Sponsor Center

News  cth - Cynapsus Therapeutics Inc More...

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days

Analysis  cth - Cynapsus Therapeutics Inc More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports cth - Cynapsus Therapeutics IncMore...

Click above to view more mutual fund data and stats for cth - Cynapsus Therapeutics Inc.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings
Stock Price Quote: cth Cynapsus Therapeutics Inc - XTSX - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: cyio - CYIOS Corp  |  Next: cyno - Cynosure Inc Class A